首页 正文

AT1 antagonists: a patent review (2008 - 2012)

{{output}}
Introduction: For two decades a class of pharmaceutical molecules with proved beneficial therapeutic properties, especially in hypertension, has been introduced in the market aiming to specifically prevent the detrimental effects... ...